Immunotherapy before surgery shrinks lung tumors in Early-Stage patients
NCT ID NCT03158129
First seen May 12, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study tested giving immunotherapy drugs (nivolumab alone or with ipilimumab or chemotherapy) before surgery to people with early-stage non-small cell lung cancer. The goal was to see if these treatments could shrink tumors and improve outcomes. About 101 patients took part, and the results showed that many had a major reduction in tumor cells, with some having no cancer left at the time of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.